[HTML][HTML] Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer
E Murce, E Spaan, S Beekman, L van den Brink… - Pharmaceuticals, 2023 - mdpi.com
Small-molecule drug conjugates (SMDCs) are compounds in which a therapeutic payload is
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer
E Murce, E Spaan, S Beekman… - …, 2023 - search.proquest.com
Small-molecule drug conjugates (SMDCs) are compounds in which a therapeutic payload is
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer.
E Murce, E Spaan, S Beekman… - Pharmaceuticals …, 2023 - europepmc.org
Small-molecule drug conjugates (SMDCs) are compounds in which a therapeutic payload is
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
[PDF][PDF] Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer
E Murce, E Spaan, S Beekman, L van den Brink… - …, 2023 - pure.eur.nl
Small-molecule drug conjugates (SMDCs) are compounds in which a therapeutic payload is
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
[HTML][HTML] Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer
E Murce, E Spaan, S Beekman, L van den Brink… - …, 2023 - ncbi.nlm.nih.gov
Small-molecule drug conjugates (SMDCs) are compounds in which a therapeutic payload is
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer.
E Murce, E Spaan, S Beekman… - Pharmaceuticals …, 2023 - search.ebscohost.com
Small-molecule drug conjugates (SMDCs) are compounds in which a therapeutic payload is
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer
E Murce, E Spaan, S Beekman… - Pharmaceuticals …, 2023 - pubmed.ncbi.nlm.nih.gov
Small-molecule drug conjugates (SMDCs) are compounds in which a therapeutic payload is
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
[引用][C] Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer
E Murce, E Spaan, S Beekman, L van den Brink… - …, 2023 - europepmc.org
Small-molecule drug conjugates (SMDCs) are compounds in which a therapeutic payload is
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
[PDF][PDF] Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer
E Murce, E Spaan, S Beekman, L van den Brink… - …, 2023 - pure.eur.nl
Small-molecule drug conjugates (SMDCs) are compounds in which a therapeutic payload is
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …
conjugated to a targeting vector, for specific delivery to the tumor site. This promising …